The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia (Journal article)

Hatzimichael, E./ Dasoula, A./ Shah, R./ Syed, N./ Papoudou-Bai, A./ Coley, H. M./ Dranitsaris, G./ Bourantas, K. L./ Stebbing, J./ Crook, T.


EGLN1 and EGLN3 are members of the egg-laying-defective 9 (EglN) prolyl-hydroxylases which during normoxia catalyse hydroxylation of the hypoxia-inducible factor (HIF)-1alpha, thereby promoting its ubiquitination by a complex containing the von Hippel-Lindau (VHL) tumour suppressor. EGLN3 also has pro-apoptotic activity in some cell types. Analyses of a well-characterised series of cases of plasma cell dyscrasias, including multiple myeloma (MM), Waldenstrom's macroglobulinaemia (WM) and monoclonal gammopathy of undetermined significance (MGUS) surprisingly demonstrated that the CpG island of EGLN3, and not EGLN1, is frequently methylated in these disorders. Multiple myeloma patients with a methylated EGLN3 promoter showed trends towards an increased risk of death, bone lytic lesions, anaemia, advanced stage of disease and the presence of extramedullary disease. Those individuals with methylation in the EGLN3 CpG island also had significantly lower albumin levels. These data suggest that the prolyl-hydroxylases may be a novel class of potential tumour suppressors in plasma cell neoplasia that warrant further investigation with regard to their potential utility as biomarkers. Moreover, we observed that EGLN3 is also methylated at high frequency in B-cell lymphoma subtypes, implying that loss of EGLN3 is an important epigenetic event not only in plasma cell neoplasias but also in B-cell neoplasias.
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Aged,Cell Line, Tumor/enzymology,CpG Islands/*genetics,*DNA Methylation,DNA, Neoplasm/genetics,Dioxygenases/biosynthesis/*genetics,Female,Gene Expression Regulation, Enzymologic,Gene Expression Regulation, Neoplastic,*Gene Silencing,Humans,Lymphoma, B-Cell/classification/enzymology/genetics,Male,Middle Aged,Monoclonal Gammopathy of Undetermined Significance/enzymology/genetics,Multiple Myeloma/complications/enzymology/genetics/mortality,Paraproteinemias/enzymology/*genetics,Procollagen-Proline Dioxygenase/biosynthesis/*genetics,Waldenstrom Macroglobulinemia/enzymology/genetics
URI: http://olympias.lib.uoi.gr/jspui/handle/123456789/23587
ISSN: 1600-0609
Link: http://www.ncbi.nlm.nih.gov/pubmed/19737309
http://onlinelibrary.wiley.com/store/10.1111/j.1600-0609.2009.01344.x/asset/j.1600-0609.2009.01344.x.pdf?v=1&t=h2boq8ws&s=0e72d00a6c72d669e1b18e41a9f70a1f034b400d
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Hatzimichael-2010-The prolyl-hydroxyla.pdf127.13 kBAdobe PDFView/Open    Request a copy



 Please use this identifier to cite or link to this item:
http://olympias.lib.uoi.gr/jspui/handle/123456789/23587
  This item is a favorite for 0 people.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.